Arcturus Therapeutics Ltd (ARCT)
8.90 x 5 9.84 x 2
Post-market by (Cboe BZX)
9.70 +0.35 (+3.74%) 04/11/25 [NASDAQ]
8.90 x 5 9.84 x 2
Post-market 9.52 -0.18 (-1.86%) 18:33 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,941 | -29,725 | 9,349 | -203,674 | -72,148 |
| Depreciation Amortization | 3,544 | 2,957 | 1,527 | 1,193 | 882 |
| Accounts receivable | 28,090 | -29,300 | 603 | -1,242 | 54 |
| Accounts payable and accrued liabilities | 1,915 | -2,238 | -3,112 | -769 | 4,812 |
| Other Working Capital | -20,809 | 7,381 | -12,557 | 32,625 | 21,216 |
| Other Operating Activity | 8,454 | 32,826 | 36,183 | 36,824 | 2,323 |
| Operating Cash Flow | $-59,747 | $-18,099 | $31,993 | $-135,043 | $-42,861 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -648 | -2,901 | -7,726 | -3,406 | -1,742 |
| Investing Cash Flow | $-648 | $-2,901 | $-7,726 | $-3,406 | $-1,742 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,000 | N/A | 46,599 | N/A |
| Debt Repayment | N/A | -47,364 | -5,000 | N/A | N/A |
| Common Stock Issued | 5,418 | 3,277 | 2,141 | 1,417 | 436,145 |
| Financing Cash Flow | $5,418 | $-24,087 | $-2,859 | $48,016 | $436,145 |
| Beginning Cash Position | 348,890 | 393,977 | 372,569 | 463,002 | 71,460 |
| End Cash Position | 293,913 | 348,890 | 393,977 | 372,569 | 463,002 |
| Net Cash Flow | $-54,977 | $-45,087 | $21,408 | $-90,433 | $391,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,747 | -18,099 | 31,993 | -135,043 | -42,861 |
| Capital Expenditure | -648 | -2,901 | -7,726 | -3,406 | -1,742 |
| Free Cash Flow | -60,395 | -21,000 | 24,267 | -138,449 | -44,603 |